Patient Selection For Port Delivery Device
Panelists discuss how patients experiencing a high treatment burden with frequent anti-VEGF injections every 4-8 weeks are optimal candidates for the port delivery system, which can help reduce their number of clinic visits while maintaining therapeutic effectiveness.
Video content above is prompted by the following:
- Which patients are ideal candidates for this anti-VEGF delivery method?
- Patients with frequent anti-VEGF treatment burden (4-8 weeks)
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Recent Videos
Related Content
